Nanorobots are emerging technology in the field of medical science. Nanorobots involve the administration of tiny devices to the arteries used for diagnostic and treatment purpose. Nanorobots are mostly used for the neurology and oncology treatment. Currently, the application of nanorobot for medical science is limited; however, it is expected to make a great impact in the near future. Researchers demonstrated that nanorobots prevent side effects for cancer treatment caused due to chemotherapy and other biological therapies. Hence, virtual 3D nanorobots are projected to be a viable alternative for cancer treatment in the future. Although substantial breakthroughs have been made, there is still much work to be implemented before the concept becomes a reality. The medical applications of 3D nanorobot include dentistry, brain aneurysm, cancer detection and treatment, and gene therapy.
The global market for virtual 3D nanorobots has a substantial growth worldwide due to technological innovations, introduction of advanced medical equipment, and advancement of health care infrastructure in developed nations. Moreover, advances in mobile penetration, connectivity, and ICT services are estimated to further accentuate the market growth. Mobile access is becoming ubiquitous worldwide. Developed markets such as Australia, Korea, the U.S., the U.K., Sweden, and Germany already have mobile penetration greater than 100%. This offers significant growth opportunities in the market. Additionally, favorable government support, rise in health care infrastructure, and rapid technological innovations toward health care services accentuate growth of the market.
The virtual 3D nanorobots market, with advancement in technology, in developing countries is anticipated to expand at a promising rate during the forecast period. According to the UN Telecommunication Union’s (ITU) annual ICT report “Measuring the Information Society 2011,” the Republic of Korea is one of the world’s most technologically advanced economy for health care. Moreover, the mobile devices, if effectively leveraged, can help drive health care accessibility and affordability across the world. Therefore, rise in technological advancement and increase in efforts toward the development of innovative medical (mobile) technologies are expected to fuel demand for virtual 3D nanorobots for health care across the world.
Geographically, the global virtual 3D nanorobots market has been segmented into North America, Europe, Asia Pacific, Latin America (LATAM), and Middle East & Africa (MEA). North America accounted for a significantly large share of the global virtual 3D nanorobots market in 2014. The U.S. accounted for majority of the market share in the region. The virtual 3D nanorobots market offers immense growth potential in this region owing to timely technological upgrade, increase in awareness among patients, and continuous evolution of information technology. Countries in Western Europe (Germany, France, Italy, and Spain) offer lucrative opportunities in the field of 3D nanorobot, majorly due to increase in implementation of technologically advanced devices and rise in government initiatives toward development of well-equipped health care centers. Moreover, Asia Pacific and Middle East & Africa are expected to expand at a fast growth rate during the forecast period. Untapped opportunities, improvement in health care infrastructure, increase in awareness about available and innovative nanorobotics services, and favorable government initiatives are the major factors fueling the growth of the virtual 3D nanorobots market in these regions. Latin America majorly includes countries in Central and South America such as Mexico, Brazil, Argentina, and Chile. Latin America is one of the lucrative markets for virtual 3D nanorobots. Brazil and Mexico are significantly large markets in the region.
Key players operating in the global virtual 3D nanorobots market include Zymergen, Gingko Bioworks, and Synthace.
Note : All statements of fact, opinion, or analysis expressed in reports are those of the respective analysts. They do not necessarily reflect formal positions or views of Transparency Market Research.